Given its ability to suppress inflammatory responses, IL-10 is being investigated as a potential therapeutic agent for autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease (IBD), and multiple sclerosis. This evidence concerns the gene IL10 and inflammatory bowel disease.